SARS-CoV-2:

Nitchakan Darai1, Piyatida Pojtanadithee2, Kamonpan Sanachai3

  • 1Center of Excellence in Biocatalyst and Sustainable Biotechnology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand.

PubMed
概括

研究人员通过计算选化合物确定了潜在的COVID-19治疗方法. E912-0363已成为SARS-CoV-2主要蛋白酶 (Mpro) 的有前途的抑制剂,显示出治疗潜力.